Get startedLog in
    Picture of Newbury Pharmaceuticals AB logo

    NEWBRY — Newbury Pharmaceuticals AB News Story

    0.000.00%
    se flag iconLast trade - 00:00
    Consumer DefensivesHighly SpeculativeMicro CapMomentum Trap
    All News

    Brief: Newbury Pharmaceuticals Q1 2022 EBITDA Loss Widens To SEK 5.4 Mln

    Picture of Newbury Pharmaceuticals AB logoNewbury Pharmaceuticals AB
    11/01/2023 08:16
    Jan 11 (Reuters) - Newbury Pharmaceuticals AB
 NEWBRY.ST :
    * NEWBURY PHARMACEUTICALS INTERIM REPORT SEPTEMBER 2022 –
NOVEMBER
2022
    * Q1 NET REVENUE WAS 258 (0) TKR
    * Q1 EBITDA LOSS SEK 5.4 MILLION VERSUS LOSS SEK 3.6 MILLION
YEAR
AGO

Source text for Eikon:  ID:nMFN3t6tLH 
Further company coverage:  NEWBRY.ST 
 (Gdansk Newsroom)
 ((gdansk.newsroom@thomsonreuters.com; +48 58 7696600;))

    Recent news on Newbury Pharmaceuticals AB

    See all news